Publication | Open Access

BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

Tumor Mutational BurdenDeath Ligand 1MedicineImmunologyCancer GenomicsImmune Checkpoint InhibitorImmune Check-point InhibitorsCancer GeneticsCancer BiologyRadiation OncologyLung CancerTumor Biology